Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Leishmaniasis and AIDS co-infection: the Spanish example.

Literature DB >> 15275487

Leishmaniasis and AIDS co-infection: the Spanish example.

Abstract

There are an estimated 300 instances of Leishmania/HIV co-infection, of which 200 have occurred in Spain. Jorge Alvar here asks: is there an epidemiological or immunological basis for this high proportion?

Entities: Disease

Year: 1994 PMID： 15275487 DOI： 10.1016/0169-4758(94)90270-4

Source DB: PubMed Journal: Parasitol Today ISSN： 0169-4758

Keyword Cloud
Cited

21 in total

1. Selective effect of 2',6'-dihydroxy-4'-methoxychalcone isolated from Piper aduncum on Leishmania amazonensis.

Authors: E C Torres-Santos; D L Moreira; M A Kaplan; M N Meirelles; B Rossi-Bergmann
Journal: Antimicrob Agents Chemother Date: 1999-05 Impact factor: 5.191

2. Mannan-binding lectin enhances susceptibility to visceral leishmaniasis.

Authors: I K Santos; C H Costa; H Krieger; M F Feitosa; D Zurakowski; B Fardin; R B Gomes; D L Weiner; D A Harn; R A Ezekowitz; J E Epstein
Journal: Infect Immun Date: 2001-08 Impact factor: 3.441

3. Comparison of the indirect immunofluorescent antibody test and the direct agglutination test for serodiagnosis of visceral leishmaniasis in HIV-infected subjects.

Authors: L Nigro; C Vinci; F Romano; R Russo
Journal: Eur J Clin Microbiol Infect Dis Date: 1996-10 Impact factor: 3.267

9. Immunoblot analysis of the humoral immune response to Leishmania donovani polypeptides in cases of human visceral leishmaniasis: its usefulness in prognosis.

Authors: Promod Kumar; Kalpana Pai; Kiran Tripathi; H P Pandey; Shyam Sundar
Journal: Clin Diagn Lab Immunol Date: 2002-09

10. The cured immune phenotype achieved by treatment of visceral leishmaniasis in the BALB/c mouse with a nonionic surfactant vesicular formulation of sodium stibogluconate does not protect against reinfection.

Authors: K C Carter; A J Baillie; A B Mullen
Journal: Clin Diagn Lab Immunol Date: 1999-01

Leishmaniasis and AIDS co-infection: the Spanish example.

1. Selective effect of 2',6'-dihydroxy-4'-methoxychalcone isolated from Piper aduncum on Leishmania amazonensis.

2. Mannan-binding lectin enhances susceptibility to visceral leishmaniasis.

3. Comparison of the indirect immunofluorescent antibody test and the direct agglutination test for serodiagnosis of visceral leishmaniasis in HIV-infected subjects.

4. Mediterranean leishmaniasis in HIV-infected patients: epidemiological, clinical, and diagnostic features of 22 cases.

Review 5. Leishmania and human immunodeficiency virus coinfection: the first 10 years.

6. Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania donovani.

7. PCR and in vitro cultivation for detection of Leishmania spp. in diagnostic samples from humans and dogs.

8. Injecting drug use as risk factor for visceral leishmaniasis in AIDS patients.

9. Immunoblot analysis of the humoral immune response to Leishmania donovani polypeptides in cases of human visceral leishmaniasis: its usefulness in prognosis.

10. The cured immune phenotype achieved by treatment of visceral leishmaniasis in the BALB/c mouse with a nonionic surfactant vesicular formulation of sodium stibogluconate does not protect against reinfection.